NCT06253351Completed
Real-world Use of Hybrid Closed Loop in Adolescents and Young Adults 15-25 Years of Age with Type 1 Diabetes
Source: ClinicalTrials.gov · Last updated 26 Nov 2024
Brief summary (registry, in English)
The purpose of this study is to determine the effect of hybrid closed loop on glycemic outcomes in young patients aged between 15 and 25 years old with type 1 diabetes, whatever is their initial metabolic control.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 101 (actual)
- First submitted
- 2 Feb 2024
- Start date
- 13 Mar 2024
- Primary completion date
- 6 May 2024
- Lead sponsor
- Centre Hospitalier Sud Francilien
- Diseases
- Type 1 diabetes
- NCT number
- NCT06253351
What you commit to
- Study type: Observational
- Participants enrolled: 101
- From 13 Mar 2024 to the primary completion date, 6 May 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Informed patient that have been opposed for their data collect
Who the study is looking for
- Patient aged between 15 and 25 years old
- Type 1 diabetes since at least 1 year at the moment of instauring HCL
- At least 3 months of HCL use
Age in the registry: 15 years to 25 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre Hospitalier Sud Francilien Coordinator of this site? Confirm its status | Corbeil-Essonnes | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.